Corporate | 16 December 2011 10:27
|
STRATEC Biomedical AG / Key word(s): Miscellaneous
STRATEC to present at two upcoming Capital Market Conferences Birkenfeld, December 16, 2011 STRATEC Biomedical AG (Frankfurt: SBS; Prime Standard, TecDAX) today announced that the company will present at two international Capital Market Conferences in January 2012:
30
th
Annual J.P. Morgan Healthcare Conference
CA Cheuvreux – 11
th
German Corporate Conference
Copies of the company presentation and links to the webcast, if available, will be provided at www.stratec.com > Investor Relations > Financial Calendar.
About STRATEC
The company develops its products on the basis of its own patented technologies. Shares in the company (ISIN: DE0007289001) are traded in the Prime Standard segment of the Frankfurt Stock Exchange and are listed in the TecDAX select index of the German Stock Exchange. The STRATEC Group consists of the publicly listed parent company STRATEC Systems AG and of subsidiaries and second-tier subsidiaries in Germany, the USA, the UK, Switzerland and Romania.
Further information can be obtained from:
End of Corporate News 16.12.2011 Dissemination of a Corporate News, transmitted by DGAP – a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. DGAP’s Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de |
| Language: | English | |
| Company: | STRATEC Biomedical AG | |
| Gewerbestr. 37 | ||
| 75217 Birkenfeld | ||
| Germany | ||
| Phone: | +49 (0)7082 7916 0 | |
| Fax: | +49 (0)7082 7916 999 | |
| E-mail: | info@stratec.com | |
| Internet: | www.stratec.com | |
| ISIN: | DE0007289001 | |
| WKN: | 728900 | |
| Listed: | Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Düsseldorf, München, Stuttgart | |
| End of News | DGAP News-Service |
|
|
| 150058 16.12.2011 |